High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$0
$0
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
BCRX
M
BIOCRYST PHARMACEUTICALS INC
Gayer Charles K
• President
Equity Compensation
2025-12-22
$371,896x6
|
||||||
| BCRX |
BIOCRYST PHARMACEUTICALS INC
|
President
Equity Compensation
|
2025-12-22 | $371,896x6 | M | Form 4 |